Evaluation of the von Willebrand factor (VWF) inhibitor in a large cohort of European and Iranian patients previously diagnosed with type 3 von Willebrand disease (VWD) enrolled into the 3WINTER-IPS Project

Posted by | Jul 31, 2019 | |

Luciano Baronciani1, Ulrich Budde2, Francesca Stufano1, Flora Peyvandi1,3, Anne Goodeve4, Reinhard...

Read More